• Bextra®
• Alert
• Alternative
• Attorney
• Claim
• Class Action
• Complications
• Danger
• Depression
• Dosage
• Effects
• Heart
• Information
• Injury
• Lawsuit
• Litigation
• Medication
• Problems
• Reaction
• Recall
• Risks
• Safety
• Stroke
• Warnings
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Bextra® depression can be a psychological symptom that is caused by the primary condition for which Bextra® is used to treat. Bextra® (valdecoxib) is a COX-2 selective non-steroidal anti-inflammatory prescription drug (NSAID) manufactured by Pfizer. The FDA approved Bextra® in 2001 to treat the pain associated with osteoarthritis, rheumatoid arthritis, menstrual cramps, and other chronic pain conditions. Doctors may also prescribe Bextra® for off-label uses such as acute pain treatment and the like.

Bextra® depression may be caused by the effects of the original condition for which it is used to treat. It is estimated that over twenty three million Americans suffer from arthritis. Approximately ten percent of all menstruating women are incapacitated by the pain associated with primary dysmenorrhea every month. Approximately 3.7 million Americans suffer from fibromyalgia, a condition characterized by chronic pain in the muscles and soft tissues surrounding joints.

It is estimated that one third of all fibromyalgia patients also suffer from depression as a result of their condition. Arthritis, more common in older populations, is a debilitating chronic pain condition that is also commonly coupled with depression symptoms. Depression can be a consequence of any condition which causes a patient perpetual pain.

In some cases, treating chronic pain conditions safely with NSAIDs can reduce a patient’s symptoms of depression. Studies have also shown that treating depression with medication and other therapies can actually improve a patient’s chronic pain condition. Many studies have established a link between depression and chronic inflammatory conditions.

Bextra® depression may therefore be a result of the primary chronic pain condition. It is possible that for some patients Bextra® treatment will alleviate pain and potentially reduce their depressive symptoms. Bextra® is not intended to treat any of the symptoms of depression directly. Any improvement in a patient’s depression is generally considered incidental and not a direct function of Bextra® use. In very rare cases Bextra® depression is actually a side effect of Bextra® use.

If you have experienced Bextra® depression or have questions about Bextra®, chronic pain conditions, and depression, you may wish to speak to your health care provider about these concerns in greater detail. Bextra® users should also speak to their doctor about their risks and benefits of taking Bextra®, as this medication has been associated with serious skin and cardiovascular side effects.

If you have suffered from Bextra® depression or any other side effects, you may wish to explore your legal rights and options. A qualified and experienced attorney can evaluate your case to determine if you are eligible to seek compensation for your Bextra® depression losses.

"Bextra Suit Filed"

Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.

Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...

» Read More

"FDA issues drug warnings on its Web site"

The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...

» Read More

"FDA to listen to outside advisers in hopes of improving drug-monitoring system"

After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...

» Read More

• Accutane® |
• Acetaminophen |
• Actavis Information |
• Actos® |
• Amiodarone |
• Trasylol® - Aprotinin Injection |
• Avandia® |
• Baycol® |
• Bextra® |
• Botox |
• Byetta® |
• Celebrex |
• Cellcept |
• Chantix® |
• Cipro Side Effects |
• Crestor |
• Darvocet |
• Darvon® |
• Defective Drug FAQ |
• Common Defective Drugs |
• Depakote® |
• Drug Company Information |
• Defective Drug Side Effects |
• Duragesic Patch |
• Exjade |
• Fentanyl |
• Fen Phen |
• Fleet Phospho Soda |
• Fluoroquinolone Antibiotics |
• Fosamax |
• Gadolinium |
• Gardasil |
• Gleevec |
• Heparin |
• Humira and Remicade |
• Hydroquinone |
• Hydroxycut |
• Januvia® and Janumet® Information |
• Kava Kava |
• Ketek |
• Lariam |
• Levaquin |
• Lupron (Leuprolide) |
• Meridia |
• Multaq® |
• Naproxen (Aleve) |
• Natrecor |
• Neurontin |
• Nexium® (Esomeprazole Magnesium) Heartburn Relief |
• NuvaRing® |
• Ocella Information |
• Osteonecrosis and Fosamax |
• Oxycontin |
• Palladone |
• Paxil |
• Permax |
• Plavix |
• PPA |
• Pradaxa® |
• Prevacid® |
• Prilosec® |
• Procrit |
• Propecia® (Finasteride) |
• Propoxyphene |
• Protonix® |
• Protopic |
• Prozac |
• What is Quinine? |
• Rapamune® Lawyer |
• Raptiva |
• Reglan |
• Remicade Lawsuit |
• Rezulin |
• Risperdal |
• Ritalin |
• Serevent |
• Seroquel |
• Serzone |
• Tequin |
• Thimerosal |
• Topamax® (Topiramate) |
• Viagra® |
• Wellbutrin® |
• Xenical |
• Yasmin® |
• Yaz Birth Control Lawyer |
• Zelnorm |
• Zocor® Medication Information |
• Zoloft |
• Zyprexa |